We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOUS
301
DELISTED
Anywhere Real Estate
HOUS
| $3.5M | 0.07% |
107,959
-69,641
| -39% | -$2.11M |
|
302
Astronics
ATRO
$3.5B
| $3.5M | 0.07% |
158,486
+51,092
| +48% | +$1.14M |
|
303
Public Storage
PSA
$58.8B
| $3.5M | 0.07% |
16,780
-26,345
| -61% | -$5.66M |
|
304
WaFd
WAFD
$2.72B
| $3.49M | 0.07% |
105,019
+6,400
| +6% | +$212K |
|
305
Boise Cascade
BCC
$2.69B
| $3.47M | 0.07% |
114,120
+63,950
| +127% | +$1.87M |
|
306
Caterpillar
CAT
$412B
| $3.44M | 0.07% |
+32,030
| New | +$3.25M |
|
|
VRNT
307
DELISTED
Verint Systems
VRNT
| $3.42M | 0.07% |
+165,073
| New | +$3.41M |
|
308
Brixmor Property Group
BRX
$9.81B
| $3.41M | 0.07% |
190,750
+42,340
| +29% | +$821K |
|
|
BDN
309
Brandywine Realty Trust
BDN
$533M
| $3.41M | 0.07% |
+194,414
| New | +$3.34M |
|
|
ESND
310
DELISTED
Essendant Inc.
ESND
| $3.38M | 0.07% |
227,621
+92,462
| +68% | +$1.46M |
|
|
NXGN
311
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.36M | 0.07% |
195,111
+70,341
| +56% | +$1.07M |
|
312
Philip Morris
PM
$298B
| $3.35M | 0.07% |
28,550
+9,600
| +51% | +$1.11M |
|
|
GHDX
313
DELISTED
Genomic Health, Inc.
GHDX
| $3.35M | 0.07% |
102,980
-2,450
| -2% | -$77.6K |
|
314
American Financial Group
AFG
$11.7B
| $3.31M | 0.07% |
33,344
-6,180
| -16% | -$605K |
|
315
Kulicke & Soffa
KLIC
$5.55B
| $3.31M | 0.07% |
173,882
-45,369
| -21% | -$955K |
|
|
MSGN
316
DELISTED
MSG Networks Inc.
MSGN
| $3.29M | 0.07% |
146,466
+31,722
| +28% | +$726K |
|
317
EastGroup Properties
EGP
$11.5B
| $3.27M | 0.07% |
39,073
+900
| +2% | +$72.5K |
|
|
MNDT
318
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3.27M | 0.07% |
215,120
+41,500
| +24% | +$589K |
|
|
RPXC
319
DELISTED
RPX Corporation
RPXC
| $3.27M | 0.07% |
234,258
+106,858
| +84% | +$1.42M |
|
320
SLM Corp
SLM
$4.56B
| $3.26M | 0.07% |
283,840
+217,540
| +328% | +$2.48M |
|
|
GCI
321
DELISTED
Gannett Co., Inc
GCI
| $3.25M | 0.07% |
373,212
+9,200
| +3% | +$76K |
|
322
Macy's
M
$6.14B
| $3.25M | 0.07% |
139,660
-38,990
| -22% | -$999K |
|
323
Aptiv
APTV
$11.9B
| $3.22M | 0.07% |
+36,780
| New | +$3.07M |
|
324
AeroVironment
AVAV
$8.03B
| $3.21M | 0.07% |
83,962
+5,120
| +6% | +$155K |
|
|
SHLM
325
DELISTED
Schulman (A.) Inc
SHLM
| $3.2M | 0.07% |
100,098
+60,798
| +155% | +$1.81M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.